These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
462 related articles for article (PubMed ID: 37697042)
1. Artificial intelligence for natural product drug discovery. Mullowney MW; Duncan KR; Elsayed SS; Garg N; van der Hooft JJJ; Martin NI; Meijer D; Terlouw BR; Biermann F; Blin K; Durairaj J; Gorostiola González M; Helfrich EJN; Huber F; Leopold-Messer S; Rajan K; de Rond T; van Santen JA; Sorokina M; Balunas MJ; Beniddir MA; van Bergeijk DA; Carroll LM; Clark CM; Clevert DA; Dejong CA; Du C; Ferrinho S; Grisoni F; Hofstetter A; Jespers W; Kalinina OV; Kautsar SA; Kim H; Leao TF; Masschelein J; Rees ER; Reher R; Reker D; Schwaller P; Segler M; Skinnider MA; Walker AS; Willighagen EL; Zdrazil B; Ziemert N; Goss RJM; Guyomard P; Volkamer A; Gerwick WH; Kim HU; Müller R; van Wezel GP; van Westen GJP; Hirsch AKH; Linington RG; Robinson SL; Medema MH Nat Rev Drug Discov; 2023 Nov; 22(11):895-916. PubMed ID: 37697042 [TBL] [Abstract][Full Text] [Related]
2. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics. Koromina M; Pandi MT; Patrinos GP OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216 [TBL] [Abstract][Full Text] [Related]
3. Machine learning approaches and their applications in drug discovery and design. Priya S; Tripathi G; Singh DB; Jain P; Kumar A Chem Biol Drug Des; 2022 Jul; 100(1):136-153. PubMed ID: 35426249 [TBL] [Abstract][Full Text] [Related]
4. Relevant Applications of Generative Adversarial Networks in Drug Design and Discovery: Molecular Lin E; Lin CH; Lane HY Molecules; 2020 Jul; 25(14):. PubMed ID: 32708785 [TBL] [Abstract][Full Text] [Related]
5. Artifical intelligence: a virtual chemist for natural product drug discovery. Arora S; Chettri S; Percha V; Kumar D; Latwal M J Biomol Struct Dyn; 2024 Apr; 42(7):3826-3835. PubMed ID: 37232451 [TBL] [Abstract][Full Text] [Related]
6. Learning from Nature: From a Marine Natural Product to Synthetic Cyclooxygenase-1 Inhibitors by Automated De Novo Design. Friedrich L; Cingolani G; Ko YH; Iaselli M; Miciaccia M; Perrone MG; Neukirch K; Bobinger V; Merk D; Hofstetter RK; Werz O; Koeberle A; Scilimati A; Schneider G Adv Sci (Weinh); 2021 Aug; 8(16):e2100832. PubMed ID: 34176236 [TBL] [Abstract][Full Text] [Related]
7. New avenues in artificial-intelligence-assisted drug discovery. Cerchia C; Lavecchia A Drug Discov Today; 2023 Apr; 28(4):103516. PubMed ID: 36736583 [TBL] [Abstract][Full Text] [Related]
8. Exploring the artificial intelligence and machine learning models in the context of drug design difficulties and future potential for the pharmaceutical sectors. Shiammala PN; Duraimutharasan NKB; Vaseeharan B; Alothaim AS; Al-Malki ES; Snekaa B; Safi SZ; Singh SK; Velmurugan D; Selvaraj C Methods; 2023 Nov; 219():82-94. PubMed ID: 37778659 [TBL] [Abstract][Full Text] [Related]
9. Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents. Kashyap K; Siddiqi MI Mol Divers; 2021 Aug; 25(3):1517-1539. PubMed ID: 34282519 [TBL] [Abstract][Full Text] [Related]
10. Artificial intelligence in microbial natural product drug discovery: current and emerging role. Sahayasheela VJ; Lankadasari MB; Dan VM; Dastager SG; Pandian GN; Sugiyama H Nat Prod Rep; 2022 Dec; 39(12):2215-2230. PubMed ID: 36017693 [TBL] [Abstract][Full Text] [Related]
11. Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery. Yang X; Wang Y; Byrne R; Schneider G; Yang S Chem Rev; 2019 Sep; 119(18):10520-10594. PubMed ID: 31294972 [TBL] [Abstract][Full Text] [Related]
12. Recent Progress of Deep Learning in Drug Discovery. Wang F; Diao X; Chang S; Xu L Curr Pharm Des; 2021; 27(17):2088-2096. PubMed ID: 33511933 [TBL] [Abstract][Full Text] [Related]
13. From machine learning to deep learning: progress in machine intelligence for rational drug discovery. Zhang L; Tan J; Han D; Zhu H Drug Discov Today; 2017 Nov; 22(11):1680-1685. PubMed ID: 28881183 [TBL] [Abstract][Full Text] [Related]
14. Data Integration Using Advances in Machine Learning in Drug Discovery and Molecular Biology. Hudson IL Methods Mol Biol; 2021; 2190():167-184. PubMed ID: 32804365 [TBL] [Abstract][Full Text] [Related]
15. Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Tripathi MK; Nath A; Singh TP; Ethayathulla AS; Kaur P Mol Divers; 2021 Aug; 25(3):1439-1460. PubMed ID: 34159484 [TBL] [Abstract][Full Text] [Related]
16. Artificial Intelligence, Machine Learning, and Deep Learning in Real-Life Drug Design Cases. Muller C; Rabal O; Diaz Gonzalez C Methods Mol Biol; 2022; 2390():383-407. PubMed ID: 34731478 [TBL] [Abstract][Full Text] [Related]
17. Artificial intelligence in cancer target identification and drug discovery. You Y; Lai X; Pan Y; Zheng H; Vera J; Liu S; Deng S; Zhang L Signal Transduct Target Ther; 2022 May; 7(1):156. PubMed ID: 35538061 [TBL] [Abstract][Full Text] [Related]
18. Artificial intelligence in drug discovery: recent advances and future perspectives. Jiménez-Luna J; Grisoni F; Weskamp N; Schneider G Expert Opin Drug Discov; 2021 Sep; 16(9):949-959. PubMed ID: 33779453 [No Abstract] [Full Text] [Related]
19. Artificial intelligence-guided discovery of anticancer lead compounds from plants and associated microorganisms. Li G; Lin P; Wang K; Gu CC; Kusari S Trends Cancer; 2022 Jan; 8(1):65-80. PubMed ID: 34750090 [TBL] [Abstract][Full Text] [Related]
20. Generative machine learning for de novo drug discovery: A systematic review. Martinelli DD Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]